Komen's Rejection of Porn Donation is an Obscenity
Earlier this month fundraising behemoth Susan G. Komen for the Cure flatly rejected a cash donation from one of the largest online porn sites, Pornhub.com. They went so far as to insist that Pornhub stop referring to them in the press.
Their hardline decision to reject Pornhub's offer, which is to donate one cent for every 30 views of breast-related videos on their site through October 31, amounts to yet another sad little misguided political decision by the Puritanical, conservative and elitist forces within that increasingly irrelevant organization.
As I write this, Pornhub's breast-related video watch count is at 40,153,747.
Yes, 40 million.
In the time it took me to write this much, it has already jumped over 4,400 views to 40,158,201. That's $13,386 that Komen doesn't want.
Everyone is Watching
Ladies, your spouses are watching clips at Pornhub.com. Gentlemen, your spouses are watching clips at Pornhub.
How do I know? The real question is, how can't they be? For their fundraiser, Pornhub is only counting views from two categories: 'Big Tits' and 'Small Tits.' And the count is over 40 million.
Yet they have more than 60 different video categories. Yesterday 1.49% of all Internet users across the globe visited Pornhub.
Web information site Alexa.com ranks web sites according to traffic. Look at the company this web site keeps:
#65. AOL
#66. Adobe Systems
#67. ESPN
#68. Pornhub
#69. eBay International
#70. CNN
Some critics think Pornhub is doing this for the publicity. Breaking news: A site that busy doesn't need it.
This is a sincere, if gimmicky (name a fundraiser that isn't gimmicky), attempt by Pornhub to raise money and awareness for the fight against breast cancer. That's all. Just trying to do their part.
It's not like Pornhub can be linked to breast cancer--which is more than we can say about some of the groups and organizations Komen has gladly gone to bed with in the past.
Postscript
Latest count: 40,228,818. Up over 70,000 in 30 minutes.
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
